Delivery Order SPE2DB20D2104-SPE2DB25FNACT
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Truvada 200 mg-300 mg tablets in quantities of 30 units, with a ceiling value of $13,263.60 and a firm fixed price structure. This is a non-set-aside award, meaning it was competitively awarded without restrictions. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $5,132.21 to supply Truvada 200 mg-300 mg tablets in quantities of 30 on June 25, 2025, with completion scheduled for June 26, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award. Performance will be executed from the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Truvada 200 mg-300 mg tablets in quantities of 30 units, with a ceiling value of $3,025.64. This non-set-aside contract was awarded on August 1, 2025, under a firm fixed price arrangement, with an ultimate completion date of August 4, 2025. The delivery order is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,684.40 to AmerisourceBergen Drug Corp for the supply of Truvada 200 mg-300 mg tablets in quantities of 30 units. This firm fixed-price delivery order, issued on September 16, 2025, with an ultimate completion date of September 17, 2025, represents a non-competitive set-aside award under the DLA's pharmaceutical procurement framework. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this...
- The Defense Logistics Agency awarded a delivery order valued at $33,003.17 to AmerisourceBergen Drug Corp for the supply of Truvada 200 mg-300 mg tablets in quantities of 30 units. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation, with an ultimate completion date of July 22, 2025. The award is being performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Truvada (200 mg-300 mg tablets) in quantities of 30 units. This contract, valued at $1,307.50, operates under a firm fixed-price structure with an ultimate completion date of August 18, 2025. The award was competitively procured with no set-aside designation, and performance will occur at the contractor's facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Truvada 200mg-300mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order has a ceiling value of $41,136.30 and an ultimate completion date of August 5, 2025. The contract is non-set-aside and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- This delivery order, valued at $4,212.31, was awarded on September 5, 2025, to AmerisourceBergen Drug Corp for the supply of Truvada 200-300mg tablets (30-count units) under a firm fixed price contract. The award supports the Medical Supply Chain, a defense-oriented federal agency responsible for pharmaceutical procurement for military and veteran healthcare systems. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency (DLA) awarded a $12,079.75 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of TRUVADA 100 MG-150 MG TABLET UU 30S. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,823.19 for Truvada 200 mg-300 mg tablets (30-count units) under a competitive, non-set-aside contract. The award was executed on August 22, 2025, with an ultimate completion date of August 25, 2025. The contract operates under firm fixed pricing terms and is classified as a delivery order, indicating it derives from a larger indefinite delivery...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FNACTDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,965.42 to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Truvada 200 mg-300 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through an open procurement process. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 12, 2025. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime indefinite delivery vehicle serves as a comprehensive global pharmaceutical support mechanism, enabling AmerisourceBergen to supply a broad range of pharmaceutical products, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's extensive portfolio of federal pharmaceutical contracts and its demonstrated capability to fulfill federal medical procurement requirements through competitive awards position the company as a critical vendor for the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 9/11/25 |